Year-to-date cash generated from operating
activities increased by $97 million
to $212 million, enabling continued
net debt1 reduction and a return of $61.7 million in capital to
shareholders1
Announces Completion of Group CEO Transition
and Appoints Greg Berard, CEO to the Company's Board of
Directors
TORONTO and GATINEAU, QC, Nov. 12,
2024 /CNW/ - Converge Technology Solutions Corp.
("Converge" or "the Company") (TSX: CTS) (FSE: 0ZB)
(OTCQX: CTSDF) is pleased to provide its financial results for the
three and nine months period ended September
30, 2024. All figures are in Canadian dollars unless
otherwise stated.
Third Quarter 2024 Highlights (year-over-year, unless
otherwise noted):
- Gross sales1 of $945.0
million, a decrease of $91.8
million or 8.9%;
- Gross sales organic growth1 of (8.4%) and gross
profit organic growth1 of (7.3%);
- Revenue of $630.7 million, a
decrease of $79.4 million or
11.2%;
- Gross profit decreased 9.1% to $158.3
million, representing a gross margin of 25.1%;
- Adjusted EBITDA1 decreased 22.2% to $32.1 million;
- Cash from operating activities was $48.9
million, a decrease of $47.1
million, compared to $95.9
million for the comparative period in the prior year;
- Returned $10.0 million of capital
to shareholders1 as compared to $3.1 million return of capital to shareholders in
Q3 FY23; and
- Reduced net debt1 by $30 million from $157.9
million at Q2 2024; maintaining a leverage
ratio1 below 1.0x.
Year-To-Date 2024 Highlights (year-over-year, unless
otherwise noted):
- Gross sales1 of $3.0
billion, an increase of $55.4
million or 1.9%;
- Gross sales organic growth1 of 2.0% and gross profit
organic growth1 of (1.0%);
- Revenue of $1.9 billion, a
decrease of $142.8 million;
- Gross profit decreased 1.6% to $512.8
million, representing a gross margin of 26.8%;
- Adjusted EBITDA1 decreased 3.5% to $119.4 million;
- Net loss of $171.8 million, an
increase in loss of $160.6 million,
driven by the non-cash impairment charge on the Germany segment of $176.1 million;
- Returned $61.7 million of capital
to shareholders1 as compared to $19.4 million return of capital to shareholders
for the comparative period in prior year;
- Cash from operating activities was $212.4 million, an increase of $97.3 million, compared to $115.1 million for the comparative period in the
prior year; and
- Reduced net debt1 by $81.9 million to $127.8
million, from $209.8 million
at Q4 2023.
"While adverse macroeconomic conditions led to delays in
hardware spending that impacted our third quarter results, we have
already closed about 25% of the deals contributing to our gross
profit shortfall and expect to close the remainder in Q4 and 2025.
Meanwhile, we continued to see double-digit growth in our strategic
investment areas—AI, cloud, and cybersecurity, driving growth
in software and managed services revenue in the third quarter of
2024," said Greg Berard, CEO. "Our
robust cash flow generation is a testament to our financial
strength, and we are committed to executing a strategic and
disciplined capital allocation approach to drive long-term value
creation. This will be achieved through targeted, high-impact
growth investments, while simultaneously returning a significant
amount of capital to shareholders."
Financial Summary
In $000s except per
share amounts
|
3-month
Q3
2024
|
3-month
Q3 2023
|
|
9-month
Q3
2024
|
9-month
Q3
2023
|
Gross
Sales1
|
945,006
|
1,036,760
|
|
3,014,662
|
2,959,258
|
Revenue
|
630,690
|
710,106
|
|
1,911,303
|
2,054,117
|
Gross profit
(GP)
|
158,257
|
174,090
|
|
512,813
|
521,351
|
Gross profit (GP)
%
|
25.1 %
|
24.5 %
|
|
26.8 %
|
25.4 %
|
Adjusted
EBITDA1
|
32,114
|
41,258
|
|
119,430
|
123,789
|
Adjusted EBITDA as a %
of GP1
|
20.3 %
|
23.7 %
|
|
23.3 %
|
23.7 %
|
Net loss
|
(3,309)
|
(3,316)
|
|
(171,812)
|
(11,174)
|
Adjusted net
income1
|
23,237
|
20,622
|
|
84,703
|
70,187
|
Adjusted
EPS1
|
0.12
|
0.10
|
|
0.42
|
0.34
|
Subsequent to Quarter-End
- On November 11, 2024, the Board
declared a quarterly dividend of $0.015 per common share to be paid on
December 28, 2024 to shareholders of
record at the close of business on December
10, 2024.
Financial Outlook
Converge is providing financial
guidance for the three months ended December
31, 2024 and fiscal year ended December 31, 2024 as follows:
(expressed in millions of Canadian dollars)
|
Q4 2023
Actual
|
Q4 2024
Expected
|
FY 2023
Actual
|
FY 2024
Expected
|
Revenue
|
$651.1
|
$600 - $646
|
$2,705.2
|
$2,511 -
$2,558
|
Gross profit
|
$181.5
|
$165 - $178
|
$702.9
|
$678 - $691
|
Adjusted
EBITDA
|
$46.5
|
$36 - $47
|
$170.3
|
$155 - $166
|
Note: Q4 2023 Actual and FY 2023 Actual include results of
Portage CyberTech Inc. ("Portage") which has been
deconsolidated on June 27, 2024.
Completion of Group CEO Transition
Converge is
announcing today that the previously disclosed Group CEO transition
plan has progressed ahead of schedule. As a result, the Board of
Directors (the "Board") has accepted Shaun Maine's decision to step down as Group CEO
and member of the Board, effective immediately. Greg Berard, currently CEO of Converge, has been
appointed as a member to the Company's Board of Directors.
"On behalf of the Board, I want to thank Shaun for his visionary
leadership and the profound impact he's had since co-founding the
Company in 2017," said Thomas Volk,
Chair of the Board. "We are pleased to welcome Greg Berard as the newest member of the Board.
Greg's leadership as operational CEO has been a tremendous asset to
the Company, and we look forward to the fresh perspectives and
wealth of experience that he will bring to the Board."
Conference Call Details:
Date: Tuesday, November 12th, 2024
Time: 8:00 AM Eastern Standard
Time
Participant Webcast Link:
Webcast Link – https://app.webinar.net/kPR1pwqzK50
Participant Dial-in Details with Operator
Assistance:
Conference ID: 71060
Toronto: 1-416-945-7677
North American Toll Free: 1-888-699-1199
International Toll-Free Numbers:
Germany: 498005889782
Ireland: 35315251826
Spain: 34917918582
Switzerland: 41432107274
United Kingdom: 448002797040
You may register and enter your phone number to receive an
instant automated call back via https://emportal.ink/3BJcbwy.
Recording Playback:
Webcast Link - https://app.webinar.net/kPR1pwqzK50
Toronto: 1-289-819-1450
North American Toll Free: 1-888-660-6345
Replay Code: 71060 #
Expiry Date: November
19th, 2024
Please connect at least 15 minutes prior to the conference call
to ensure time for any software download that may be required to
access the webcast. A live audio webcast accompanied by
presentation slides and archive of the conference call and webcast
will be available by visiting the Company's website
at https://convergetp.com/investor-relations/.
About Converge
Converge Technology Solutions
Corp. is a services-led, software-enabled, IT & Cloud Solutions
provider focused on delivering industry-leading solutions.
Converge's global approach delivers advanced analytics, artificial
intelligence (AI), application modernization, cloud platforms,
cybersecurity, digital infrastructure, and digital workplace
offerings to clients across various industries. The Company
supports these solutions with advisory, implementation, and managed
services expertise across all major IT vendors in the marketplace.
This multi-faceted approach enables Converge to address the unique
business and technology requirements for all clients in the public
and private sectors. For more information, visit
convergetp.com.
Summary of Condensed Consolidated Interim Statements of
Financial Position
(expressed in thousands of Canadian
dollars) (unaudited)
|
September 30,
2024
$
|
December 31,
2023
$
|
Assets
|
|
|
Current
|
|
|
|
Cash
|
180,464
|
170,419
|
|
Trade and other
receivables
|
775,026
|
803,652
|
|
Inventories
|
71,753
|
73,166
|
|
Prepaid expenses
and other assets
|
34,111
|
26,528
|
|
|
1,061,354
|
1,073,765
|
Non-current
|
|
|
|
Investment in
associates
|
27,909
|
-
|
|
Unbilled receivables
and other assets
|
202,290
|
64,158
|
|
Property, equipment and
right-of-use assets, net
|
66,621
|
75,488
|
|
Intangible assets,
net
|
272,646
|
375,181
|
|
Goodwill
|
385,022
|
564,770
|
Total
assets
|
2,015,842
|
2,153,362
|
|
|
|
|
Liabilities
|
|
|
Current
|
|
|
|
Trade and other
payables
|
976,301
|
853,655
|
|
Other financial
liabilities
|
43,799
|
54,095
|
|
Deferred
revenue
|
61,872
|
59,325
|
|
Borrowings
|
25,754
|
1,664
|
|
Income taxes
payable
|
-
|
9,286
|
|
|
1,107,726
|
978,025
|
Non-current
|
|
|
|
Accrued liabilities and
other payables
|
180,704
|
60,339
|
|
Other financial
liabilities
|
41,955
|
57,668
|
|
Borrowings
|
282,589
|
378,007
|
|
Deferred tax
liabilities
|
43,396
|
67,168
|
Total
liabilities
|
1,656,370
|
1,541,207
|
|
|
|
|
Shareholders'
equity
|
|
|
|
Common
shares
|
557,292
|
599,434
|
|
Contributed
surplus
|
15,347
|
10,970
|
|
Accumulated other
comprehensive income
|
13,009
|
3,963
|
|
Deficit
|
(226,176)
|
(28,167)
|
Total equity
attributable to shareholders of Converge
|
359,472
|
586,200
|
Non-controlling
interest ("NCI")
|
-
|
25,955
|
|
359,472
|
612,155
|
Total liabilities
and shareholders' equity
|
2,015,842
|
2,153,362
|
Summary of Condensed Consolidated Interim Statements of
Income and Comprehensive Income
(expressed in thousands
of Canadian dollars) (unaudited)
|
Three months
ended
September
30,
|
|
Nine months
ended
September
30,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Revenue
|
|
|
|
|
|
|
|
Product
|
500,881
|
|
559,646
|
|
1,503,439
|
|
1,607,932
|
Service
|
129,809
|
|
150,460
|
|
407,864
|
|
446,185
|
Total
revenue
|
630,690
|
|
710,106
|
|
1,911,303
|
|
2,054,117
|
Cost of
sales
|
472,433
|
|
536,016
|
|
1,398,490
|
|
1,532,766
|
Gross
profit
|
158,257
|
|
174,090
|
|
512,813
|
|
521,351
|
Selling, general and
administrative expenses
|
129,042
|
|
134,935
|
|
400,878
|
|
403,667
|
Income before the
following
|
29,215
|
|
39,155
|
|
111,935
|
|
117,684
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
19,961
|
|
29,456
|
|
69,382
|
|
82,239
|
Finance expense,
net
|
7,126
|
|
10,867
|
|
22,881
|
|
30,870
|
Acquisition,
integration, restructuring and other
|
2,236
|
|
2,601
|
|
10,692
|
|
10,969
|
Change in fair value of
contingent consideration
|
1,016
|
|
-
|
|
4,289
|
|
9,209
|
Share-based
compensation
|
2,761
|
|
774
|
|
4,673
|
|
2,738
|
Other expense (income),
net
|
865
|
|
(170)
|
|
1,120
|
|
(4,230)
|
Loss on loss of control
of Portage
|
-
|
|
-
|
|
117
|
|
-
|
Loss from investment in
associates
|
1,968
|
|
-
|
|
1,968
|
|
-
|
Impairment loss -
Germany segment
|
-
|
|
-
|
|
176,124
|
|
-
|
Loss before income
taxes
|
(6,718)
|
|
(4,373)
|
|
(179,311)
|
|
(14,111)
|
Income tax
recovery
|
(3,409)
|
|
(1,057)
|
|
(7,499)
|
|
(2,937)
|
Net
loss
|
(3,309)
|
|
(3,316)
|
|
(171,812)
|
|
(11,174)
|
Net loss attributable
to:
|
|
|
|
|
|
|
|
Shareholders of
Converge
|
(3,309)
|
|
(1,802)
|
|
(168,539)
|
|
(7,309)
|
Non-controlling
interest
|
-
|
|
(1,514)
|
|
(3,273)
|
|
(3,865)
|
|
(3,309)
|
|
(3,316)
|
|
(171,812)
|
|
(11,174)
|
Other comprehensive
income (loss)
|
|
|
|
|
|
|
|
Item that may be
reclassified subsequently to income (loss):
|
|
|
|
|
|
|
|
Exchange differences on
translation of foreign operations
|
(2,988)
|
|
2,891
|
|
9,046
|
|
(10,661)
|
Comprehensive
loss
|
(6,297)
|
|
(425)
|
|
(162,766)
|
|
(21,835)
|
Comprehensive loss
attributable to:
|
|
|
|
|
|
|
|
Shareholders of
Converge
|
(6,297)
|
|
1,089
|
|
(159,493)
|
|
(17,970)
|
Non-controlling
interest
|
-
|
|
(1,514)
|
|
(3,273)
|
|
(3,865)
|
|
(6,297)
|
|
(425)
|
|
(162,766)
|
|
(21,835)
|
|
|
|
|
|
|
|
|
Adjusted
EBITDA
|
32,114
|
|
41,258
|
|
119,430
|
|
123,789
|
Adjusted EBITDA as a
% of Gross profit
|
20.3 %
|
|
23.7 %
|
|
23.3 %
|
|
23.7 %
|
Summary of Condensed Consolidated Interim Statements of Cash
Flows
(expressed in thousands of Canadian
dollars) (unaudited)
|
For the three
months
ended September 30,
|
For the nine
months
ended September 30,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
|
|
|
|
|
|
Cash flows from
operating activities
|
|
|
|
|
|
|
|
Net loss
|
(3,309)
|
|
(3,316)
|
|
(171,812)
|
|
(11,174)
|
Adjustments to
reconcile net loss to net cash from operating activities
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
22,860
|
|
31,559
|
|
76,877
|
|
88,344
|
Unrealized foreign
exchange loss (gain)
|
650
|
|
-
|
|
880
|
|
(2,818)
|
Share-based
compensation
|
2,761
|
|
774
|
|
4,673
|
|
2,738
|
Finance expense, net
|
7,126
|
|
10,867
|
|
22,881
|
|
30,870
|
(Loss) gain on sale of property and
equipment
|
4
|
|
-
|
|
73
|
|
(598)
|
Change in fair value of contingent consideration
|
1,016
|
|
-
|
|
4,289
|
|
9,209
|
Impairment loss –
Germany segment
|
-
|
|
-
|
|
176,124
|
|
-
|
Loss on loss of
control of Portage
|
-
|
|
-
|
|
117
|
|
-
|
Loss from investment
in associates
|
1,968
|
|
-
|
|
1,968
|
|
-
|
Income tax
recovery
|
(3,409)
|
|
(1,057)
|
|
(7,499)
|
|
(2,937)
|
|
29,667
|
|
38,827
|
|
108,571
|
|
113,634
|
Changes in non-cash
working capital items
|
22,289
|
|
63,102
|
|
131,642
|
|
18,858
|
|
51,956
|
|
101,929
|
|
240,213
|
|
132,492
|
Income taxes
paid
|
(3,097)
|
|
(5,987)
|
|
(27,805)
|
|
(17,433)
|
Cash from operating
activities
|
48,859
|
|
95,942
|
|
212,408
|
|
115,059
|
|
|
|
|
|
|
|
|
Cash flows from
(used in) investing activities
|
|
|
|
|
|
|
|
Purchase of (proceeds
from) property, equipment and intangible assets
|
2,213
|
|
(1,593)
|
|
(1,648)
|
|
(5,041)
|
Payment of contingent
consideration
|
-
|
|
(10,899)
|
|
(19,328)
|
|
(20,834)
|
Payment of deferred
consideration
|
(508)
|
|
(14,095)
|
|
(12,375)
|
|
(43,815)
|
Payment of NCI
liability
|
-
|
|
(973)
|
|
-
|
|
(30,967)
|
Cash from (used in)
investing activities
|
1,705
|
|
(27,560)
|
|
(33,351)
|
|
(100,657)
|
|
|
|
|
|
|
|
|
Cash flows (used in)
from financing activities
|
|
|
|
|
|
|
|
Transfers from
restricted cash
|
-
|
|
(519)
|
|
-
|
|
2,068
|
Interest
paid
|
(5,801)
|
|
(10,544)
|
|
(18,130)
|
|
(25,786)
|
Dividends
paid
|
(2,922)
|
|
(2,047)
|
|
(7,925)
|
|
(4,114)
|
Payment of lease
liabilities
|
(4,677)
|
|
(4,975)
|
|
(14,793)
|
|
(15,199)
|
Repurchase of common
shares
|
(7,072)
|
|
(1,064)
|
|
(53,793)
|
|
(15,294)
|
Stock options
exercised
|
-
|
|
-
|
|
875
|
|
-
|
Repayment of notes
payable
|
-
|
|
(39)
|
|
(39)
|
|
(119)
|
Net repayment of
borrowings
|
(23,874)
|
|
(21,977)
|
|
(78,346)
|
|
(10,593)
|
Cash used in
financing activities
|
(44,346)
|
|
(41,165)
|
|
(172,151)
|
|
(69,037)
|
|
|
|
|
|
|
|
|
Net change in cash
during the period
|
6,218
|
|
27,217
|
|
6,906
|
|
(54,635)
|
Effect of foreign
exchange on cash
|
159
|
|
(439)
|
|
4,213
|
|
(34)
|
Cash derecongnized on
loss of control of Portage
|
-
|
|
-
|
|
(1,074)
|
|
-
|
Cash, beginning of the
period
|
174,087
|
|
78,443
|
|
170,419
|
|
159,890
|
Cash, end of the
period
|
180,464
|
|
105,221
|
|
180,464
|
|
105,221
|
Non-IFRS Financial Measures
This press release refers
to certain performance indicators including Adjusted EBITDA, gross
sales, gross sales organic growth, net debt, return of capital,
leverage ratio, adjusted net income ("Adjusted Net Income") and
adjusted earnings per share ("Adjusted EPS") that do not have any
standardized meaning prescribed by IFRS and may not be comparable
to similar measures presented by other companies. Management
believes that these measures are useful to most shareholders,
creditors, and other stakeholders in analyzing the Company's
operating results and can highlight trends in its core business
that may not otherwise be apparent when relying solely on IFRS
financial measures. The Company also believes that securities
analysts, investors and other interested parties frequently use
non-IFRS measures in the evaluation of issuers.
Management also uses non-IFRS measures in order to facilitate
operating performance comparisons from period to period, prepare
annual operating budgets and assess the ability to meet capital
expenditure and working capital requirements. These non-IFRS
financial measures should not be considered as an alternative to
the consolidated income (loss) or any other measure of performance
under IFRS. Investors are encouraged to review the Company's
financial statements and disclosures in their entirety, are
cautioned not to put undue reliance on non-IFRS measures and view
them in conjunction with the most comparable IFRS financial
measures.
Please see "Non-IFRS Financial & Supplementary Financial
Measures" and "Summary of Consolidated Financial Results" in the
Company's most recent Management's Discussion and Analysis, which
is available on the Company's profile on SEDAR+ at
www.sedarplus.ca, for further details on certain non-IFRS measures,
which information is incorporated by reference herein.
Adjusted EBITDA
Adjusted EBITDA represents net income or loss adjusted to
exclude amortization, depreciation, net finance expense, foreign
exchange gains and losses, other expenses and income, share-based
compensation expense, income tax expense or recovery, change
in fair value of contingent consideration, impairment loss, gain or
loss on loss of control of subsidiary, income or loss from
investment in associates and acquisition, integration,
restructuring and other expenses. Acquisition and transaction
related costs primarily consists of acquisition-related
compensation tied to continued employment of pre-existing
shareholders of the acquiree not included in the total purchase
consideration and professional fees. Integration costs primarily
consist of professional fees incurred related to integration of
acquisitions completed. Restructuring costs mainly represent
employee exit costs as a result of synergies created from
acquisitions and organizational changes.
Adjusted EBITDA is not a recognized, defined, or standardized
measure under IFRS. The Company's definition of Adjusted EBITDA
will likely differ from that used by other companies and therefore
comparability may be limited.
Adjusted EBITDA should not be considered a substitute for or in
isolation from measures prepared in accordance with IFRS.
The IFRS measure most directly comparable to Adjusted
EBITDA presented in the Company's financial statements is net
(loss) income before taxes.
The Company has reconciled Adjusted EBITDA to the most
comparable IFRS financial measure as follows:
|
|
For the three
months
ended September 30,
|
For the nine
months
ended September 30,
|
|
2024
|
2023
|
2024
|
2023
|
|
Net loss before
taxes
|
(6,718)
|
(4,373)
|
(179,311)
|
(14,111)
|
|
Depreciation and
amortization
|
19,961
|
29,456
|
69,382
|
82,239
|
|
Depreciation included
in cost of sales
|
2,899
|
2,103
|
7,495
|
6,105
|
|
Finance expense,
net
|
7,126
|
10,867
|
22,881
|
30,870
|
|
Acquisition,
integration, restructuring and other
|
2,236
|
2,601
|
10,692
|
10,969
|
|
Change in fair value of
contingent consideration
|
1,016
|
-
|
4,289
|
9,209
|
|
Share-based
compensation
|
2,761
|
774
|
4,673
|
2,738
|
|
Other expense (income),
net
|
865
|
(170)
|
1,120
|
(4,230)
|
|
Loss on loss of control
on Portage
|
-
|
-
|
117
|
-
|
|
Loss from investment in
associates
|
1,968
|
-
|
1,968
|
-
|
|
Impairment loss -
Germany segment
|
-
|
-
|
176,124
|
-
|
|
Adjusted
EBITDA
|
32,114
|
41,258
|
119,430
|
123,789
|
|
|
|
|
|
|
Adjusted EBITDA as a % of Gross Profit
The Company believes that Adjusted EBITDA as a % of gross profit
is a useful measure of the Company's operating efficiency and
profitability. This is calculated by dividing Adjusted EBITDA by
gross profit.
Adjusted Net Income and Adjusted EPS
Adjusted Net Income represents net income or loss adjusted to
exclude acquisition, integration, restructuring and other expenses,
change in fair value of contingent consideration, impairment loss,
gain or loss on loss of control of subsidiary, income or loss from
investment in associates, amortization of acquired intangible
assets, unrealized foreign exchange gain or loss, and share-based
compensation. The Company believes that Adjusted Net Income is a
more useful measure than net income as it excludes the impact of
one-time, non-cash and/or non-recurring items that are not
reflective of Converge's underlying business performance. Adjusted
EPS is calculated by dividing Adjusted Net Income by the total
weighted average shares outstanding on a basic and diluted
basis. The IFRS measure most directly comparable to Adjusted
Net Income presented in the Company's financial statements is net
income (loss) and net income (loss) per share.
The Company has provided a reconciliation to the most comparable
IFRS financial measure as follows:
|
For the three
months
|
For the nine
months
|
ended September
30,
|
ended September
30,
|
|
2024
|
2023
|
2024
|
2023
|
Net loss
|
(3,309)
|
(3,316)
|
(171,812)
|
(11,174)
|
Acquisition,
integration, restructuring and other
|
2,236
|
2,601
|
10,692
|
10,969
|
Change in fair value of
contingent consideration
|
1,016
|
-
|
4,289
|
9,209
|
Amortization on
intangibles
|
17,915
|
21,056
|
57,772
|
62,793
|
Foreign exchange loss
(gain)
|
650
|
(493)
|
880
|
(4,348)
|
Share-based
compensation
|
2,761
|
774
|
4,673
|
2,738
|
Loss on loss of control
or Portage
|
-
|
-
|
117
|
-
|
Loss from investment in
associates
|
1,968
|
-
|
1,968
|
-
|
Impairment loss-
Germany segment
|
-
|
-
|
176,124
|
-
|
Adjusted Net
Income
|
23,237
|
20,622
|
84,703
|
70,187
|
Adjusted EPS -
Basic
|
0.12
|
0.10
|
0.42
|
0.34
|
Return of capital
The Company calculates return of capital to shareholders as the
total of cash used in dividend payments and share repurchases.
Net Debt
The Company calculates net debt1 as current and
non-current borrowings) less cash.
Leverage Ratio
The Company defines leverage ratio as net debt (current and
non-current borrowings less cash) divided by trailing twelve months
Adjusted EBITDA.
Gross sales and gross sales organic growth
Gross sales, which is a non-IFRS measure, reflects the gross
amount billed to customers, adjusted for amounts deferred or
accrued. The Company believes gross sales is a useful alternative
financial metric to net revenue, the IFRS measure, as it better
reflects volume fluctuations as compared to net revenue. Under the
applicable IFRS 15 'principal vs agent' guidance, the principal
records revenue on a gross basis and the agent records commission
on a net basis. In transactions where Converge is acting as an
agent between the customer and the vendor, net revenue is
calculated by reducing gross sales by the cost of sale
amount.
The Company has provided a reconciliation of gross sales to
revenue, which is the most comparable IFRS financial measure, as
follows:
|
For the three
months
|
For the nine
months
|
ended September
30,
|
ended September
30,
|
|
2024
|
2023
|
2024
|
2023
|
Product
|
668,057
|
721,871
|
2,086,201
|
2,027,198
|
Managed services and
professional services
|
119,128
|
129,382
|
353,407
|
384,826
|
Maintenance, support
and cloud solutions
|
157,821
|
185,507
|
575,054
|
547,234
|
Gross sales
|
945,006
|
1,036,760
|
3,014,662
|
2,959,258
|
Less: adjustment for
sales transacted as agent
|
314,316
|
326,654
|
1,103,359
|
905,141
|
Revenue
|
630,690
|
710,106
|
1,911,303
|
2,054,117
|
Organic Growth
The Company measures organic growth at the gross sales and gross
profit levels, and includes the contributions under Converge
ownership in the current and comparative period(s). In calculating
organic growth, the Company therefore deducts gross sales and gross
profit generated from all corresponding prior comparable
pre-acquisition period(s) from the current reporting period(s)
included in the consolidated results.
Organic growth calculations for the three and nine-months ended
September 30, 2024, deduct gross
sales and gross profits from Portage for the three months ended
September 30, 2023 due to
deconsolidation of Portage on June 27,
2024.
Gross sales organic growth is calculated by deducting prior
period gross sales, from current period gross sales for the same
portfolio of companies. Gross sales organic growth percentage is
calculated by dividing organic growth by prior period reported
gross sales.
|
For the three
months
|
For the nine
months
|
ended September
30,
|
ended September
30,
|
|
2024
|
2023
|
2024
|
2023
|
Gross sales
|
945,006
|
1,036,760
|
3,014,662
|
2,959,258
|
Less: gross sales from
companies not owned in comparative period
|
-
|
133,891
|
-
|
593,758
|
Gross sales of
companies owned in comparative period
|
945,006
|
902,869
|
3,014,662
|
2,365,500
|
Less: prior period
gross sales(i)
|
1,031,779
|
730,571
|
2,954,277
|
2,134,178
|
Organic Growth -
$
|
(86,773)
|
172,298
|
60,385
|
231,322
|
Organic Growth -
%
|
(8.4 %)
|
23.6 %
|
2.0 %
|
10.8 %
|
(i)
|
For the three and
nine months ended September 30, 2024, Portage prior period gross
sales of $4,981 is excluded
|
Gross profit organic growth is calculated by deducting prior
period gross profit, from current period gross profit for the same
portfolio of companies. Gross profit organic growth percentage is
calculated by dividing organic growth by prior period reported
gross profit.
|
For the three
months
|
For the nine
months
|
ended September
30,
|
ended September
30,
|
|
2024
|
2023
|
2024
|
2023
|
Gross profit
|
158,257
|
174,090
|
512,813
|
521,351
|
Less: gross profit from
companies not owned in comparative period
|
-
|
20,375
|
-
|
104,212
|
Gross profit of
companies owned in comparative period
|
158,257
|
153,715
|
512,813
|
417,139
|
Less: Prior period
gross profit(ii)
|
170,639
|
139,654
|
517,900
|
381,851
|
Organic Growth -
$
|
(12,382)
|
14,061
|
(5,087)
|
35,288
|
Organic Growth -
%
|
(7.3 %)
|
10.1 %
|
(1.0 %)
|
9.2 %
|
(ii)
|
For the three and
nine months ended September 30, 2024, Portage prior period gross
profits of $3,451 is excluded
|
________________________________
|
1 This is a
Non-IFRS measure (including non-IFRS ratio) and not a recognized,
defined or a standardized measure under IFRS. See the "Non- IFRS
Financial Measures" section of this press release for definition,
uses and a reconciliation of historical non-IFRS financial measures
to the most directly comparable IFRS financial measures.
|
Forward-Looking Information
This press release contains certain "forward-looking
information" and "forward-looking statements" (collectively,
"forward-looking statements") within the meaning of
applicable Canadian securities legislation regarding Converge and
its business. Any statement that involves discussions with respect
to predictions, expectations, beliefs, plans, projections,
objectives, assumptions, future events or performance (often but
not always using phrases such as "expects", or "does not expect",
"is expected" "anticipates" or "does not anticipate", "plans",
"budget", "scheduled", "forecasts". "estimates", "believes" or
"intends" or variations of such words and phrases or stating that
certain actions, events or results "may" or "could", "would",
"might" or "will" be taken to occur or be achieved) are not
statements of historical fact and may be forward-looking
statements.
Specifically, statements regarding Converge's forecast on
revenue, gross profit and Adjusted EBITDA, expectations of future
results, performance, prospects, the markets in which it operates
or about any future intention with regard to its business and
acquisition strategies are considered forward-looking information.
The foregoing demonstrates Converge's objectives, which are not
forecasts or estimates of its financial position, but are based on
the implementation of its strategic goals, growth prospects, and
growth initiatives. The forward-looking information, including
management's assessments of, and outlook for, gross profit
and Adjusted EBITDA, are based on management's opinions, estimates
and assumptions, including, but not limited to: (i) Converge's
results of operations will continue as expected, (ii) the Company
will continue to effectively execute against its key strategic
growth priorities, (iii) the Company will continue to retain and
grow its existing customer base and market share, (iv) the Company
will be able to take advantage of future prospects and
opportunities, and realize on synergies, including with respect of
acquisitions, (v) there will be no changes in legislative or
regulatory matters that negatively impact the Company's business,
(vi) current tax laws will remain in effect and will not be
materially changed, (vii) economic conditions will remain
relatively stable throughout the period, (vii) the industries
Converge operates in will continue to grow consistent with past
experience, and (ix) those assumptions described under the heading
"About Forward-Looking Information" in the Company's Management's
Discussion and Analysis for the three and nine months ended
September 30, 2024. While these
opinions, estimates and assumptions are considered by the Company
to be appropriate and reasonable in the circumstances as of the
date of this press release, they are subject to known and unknown
risks, uncertainties, assumptions and other factors that may cause
the actual results, levels of activity, performance, or
achievements to be materially different from those expressed or
implied by such forward-looking information.
The forward looking information, including the achievement of
target revenue, gross profit and Adjusted EBITDA set out above, are
subject to significant risks including, without limitation: that
the Company will be unable to effectively execute against its key
strategic growth priorities, including in respect of acquisitions;
the Company will be unable to continue to retain and grow its
existing customer base and market share; risks related to the
Company's business and financial position; that the Company may not
be able to accurately predict its rate of growth and profitability;
risks related to economic and political uncertainty; income tax
related risks; and those risk factors discussed in greater detail
under the "Risk Factors" section of the Company's most recent
annual information form and under the heading "Risks and
Uncertainties" in the Company's most recent Management's Discussion
and Analysis, which are each available under the Company's profile
on SEDAR+ at www.sedarplus.ca. Many of these risks are beyond the
Company's control.
If any of these risks or uncertainties materialize, or if the
opinions, estimates or assumptions underlying the forward-looking
information prove incorrect, actual results or future events might
vary materially from those anticipated in the forward-looking
information. Although the Company has attempted to identify
important risk factors that could cause actual results to differ
materially from those contained in forward-looking information,
there may be other risk factors not presently known to the Company
or that the Company presently believes are not material that could
also cause actual results or future events to differ materially
from those expressed in such forward-looking information.
Although the Company bases these forward-looking statements on
assumptions that it believes are reasonable when made, the Company
cautions investors that forward-looking statements are not
guarantees of future performance and that its actual results of
operations, financial condition and liquidity and the development
of the industry in which it operates may differ materially from
those made in or suggested by the forward-looking statements
contained in this press release. In addition, even if the Company's
results of operations, financial condition and liquidity and the
development of the industry in which it operates are consistent
with the forward-looking statements contained in this press
release, those results of developments may not be indicative of
results or developments in subsequent periods.
There can be no assurance that such information will prove to be
accurate, as actual results and future events could differ
materially from those anticipated in such information. No
forward-looking statement is a guarantee of future results.
Accordingly, you should not place undue reliance on forward-looking
information, which speaks only as of the date made. The
forward-looking information contained in this press release
represents the company's expectations as of the date specified
herein, and are subject to change after such date. However, the
Company disclaims any intention or obligation or undertaking to
update or revise any forward-looking information or to publicly
announce the results of any revisions to any of those statements,
whether as a result of new information, future events or otherwise,
except as required under applicable securities laws. Comparisons of
results for current and any prior periods are not intended to
express any future trends or indications of future performance,
unless specifically expressed as such, and should only be viewed as
historical data.
All of the forward-looking information contained in this press
release is expressly qualified by the foregoing cautionary
statements.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/converge-reports-third-quarter-2024-results-302302302.html
SOURCE Converge Technology Solutions Corp.